ContraFect Corporation (NASDAQ:CFRX) saw a downside of -0.44% to close Monday at $0.09 after subtracting $0.0 on the day. The 5-day average trading volume is 28,818,520 shares of the company’s common stock. It has gained $0.1066 in the past week and touched a new high 2 times within the past 5 days. An average of 10,507,555 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 5,494,082.
CFRX’s 1-month performance is -13.30% or -$0.0070 on its low of $0.0830 reached on 01/20/23. The company’s shares have touched a 52-week low of $0.08 and high of $4.54, with the stock’s rally to the 52-week high happening on 01/10/23. YTD, CFRX has lost -5.63% or -$0.0054 and has reached a new high 3 times. However, the current price is down -98.00% from the 52-week high price.
CFRX stock has a beta of 0.40.
ContraFect Corporation’s quick ratio for the period ended September 29 was 0.80, with the current ratio over the same period at 0.80.
For the quarterly period ending September 29 this year, ContraFect Corporation’s cash and short-term investments amounted to $12.98 million against total debt of $2.98 million. Net income grew 69.01% to -$17.07 million, while revenue of -$18.09 million was -5.98% off the previous quarter. Analysts expected CFRX to announce -$0.23 per share in earnings in its latest quarter, but it posted -$0.43, representing a -87.00% surprise. CFRX stock balance sheet for the quarter ending September 29 shows that total liabilities totaled 26.14 million, with total debt at $2.98 million. Shareholders hold equity totaling $39.33 million.
Let’s look briefly at ContraFect Corporation (CFRX) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 23 January was 33.57% to suggest the stock is trending Neutral, with historical volatility in this time period at 52.30%.
The stock’s 5-day moving average is $0.0923, reflecting a -10.30% or -$0.0104 change from its current price. CFRX is currently trading -12.12% above its 20-day SMA, -66.56% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -36.29% and SMA200 by-97.66%.
Stochastic %K and %D was 25.16% and 23.57% and the average true range (ATR) pointed at 0.0126. The RSI (14) points at 35.23%, while the 14-day stochastic is at 23.75% with the period’s ATR at 0.0133. The stock’s 9-day MACD Oscillator is pointing at -0.0051 and -0.0070 on the 14-day charts.
In the most recent analyst report for ContraFect Corporation (NASDAQ: CFRX), SVB Leerink downgraded it to a Mkt perform rating. They previously had an Outperform rating on the stock. Analysts offering their rating for CFRX stock have a consensus rating for the stock as Hold. Currently, 0 brokerage advisors rate CFRX as a “sell,”, while 1 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 0 have offered a “buy” rating.